New drug shows promise for epilepsy patients with resistant seizures

In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.

Many Patients Take to Online Forum to Vent About SSRIs

Discontinuation or dosage change of selective serotonin reuptake inhibitors (SSRIs) may be more common than one would think, according to a qualitative study of online

July 18, 2023

‘If you could have the next Prozac, that’s intoxicating’: Sage’s postpartum depression triumph and the failure that followed

In 2015, psychiatrist Samantha Meltzer-Brody saw an unbelievable transformation in a new mother who had been admitted to her psychiatry clinic. Withdrawn and having suicidal

January 6, 2024

Study reveals brown fat’s built-in mechanism and potential obesity treatment

Brown fat, also known as brown adipose tissue (BAT), is a type of fat in our bodies that’s different from the white fat around our

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.